Escitalopram Solution
Product Images NDC 51672-1348

View Photos of Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 2 technical images submitted to the FDA as part of the official labeling for Escitalopram (NDC 51672-1348). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Sun Pharmaceutical Industries, Inc., these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Chemical Structure (Escitalopram 01)

Chemical Structure (Escitalopram 01)
Chemical structure diagram of Escitalopram Oxalate, the active ingredient in Escitalopram oral solution 5 mg/5 mL by Sun Pharmaceutical Industries, Inc. The structure shows key molecular components including a cyano group, a fluorophenyl group, and a dimethylamino ethyl side chain.*
FDA Label Image

Principal Display Panel (240 mL Bottle Label)

Principal Display Panel (240 mL Bottle Label)
Label for Escitalopram Oral Solution, USP 5 mg/5 mL by Taro Pharmaceuticals. The label indicates an 8 fl oz (240 mL) bottle, oral solution dosage form, with directions to dispense the medication guide and storage instructions at 20° to 25°C (68° to 77°F). Manufacturer is Taro Pharmaceuticals Inc., Canada, and distributor is Taro Pharmaceuticals U.S.A., Inc.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.